Condensed Statement of Cash Flows (Unaudited)	9 Months Ended
	Sep. 30, 2021 USD ($)
Cash Flows from Operating Activities:
Net income	$ 10,382,310
Adjustments to reconcile net loss to net cash used in operations:
Expensed offering costs	686,818
Change in fair value of warrant liabilities	(11,833,800)
Unrealized gain on investments held in Trust Account	(14,017)
Dividend income	(4,265)
Loss on sale of private placement warrants	224,333
Changes in operating assets and liabilities:
Prepaid expenses, current and non-current	(317,830)
Accrued expenses - related party	6,667
Accounts payable and accrued expenses	6,033
Franchise tax payable	139,344
Net cash used in operating activities	(724,407)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(224,000,000)
Net cash used in investing activities	(224,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from issuance of promissory note to Sponsor	125,000
Repayment of promissory note to Sponsor	(125,000)
Payment of offering costs	(626,820)
Proceeds from initial public offering, net of underwriter’s discount paid	219,520,000
Proceeds from sale of private placement warrants	6,730,000
Net cash provided by financing activities	225,648,180
Net change in cash	923,773
Cash - beginning of period
Cash - end of period	923,773
Supplemental disclosure of noncash investing and financing activities:
Initial classification of warrant liabilities	18,527,667
Deferred underwriting fee payable	7,840,000
Accretion of Class A common stock subject to redemption to redemption value	23,833,338
Reclassification of deferred offering costs to equity upon completion of the initial public offering	626,821
Forfeiture of Class B common stock	$ 15